| Vol. 12.13 – 5 April, 2023 |
| |
|
|
| Using genetically engineered and carcinogen-induced mouse models of intestinal neoplasia, scientists observed that impaired differentiation was a conserved event preceding cancer development. [Science Advances] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The sialylated cancer IgG (SIA-cIgG)/c-Met/SOX2/SIA-cIgG signaling loop was highly active in stem-like cells from many epithelial cancers and was crucial for cancer stemness in vitro and in vivo. [Cancer Research] |
|
|
|
| Researchers observed that the expression of thymocyte-expressed, positive selection-associated 1 (Tespa1) was markedly increased in hematopoietic stem cells after stress exposure. [Leukemia] |
|
|
|
| Scientists described a unique translation regulatory axis enacted by reduced expression of miR-183 in breast CSCs, which they showed targeted the eIF2Bδ subunit of guanine nucleotide exchange factor eIF2B. [Proceedings Of The National Academy Of Sciences Of The United States Of America] |
|
|
|
| Investigators developed a thiol-Michael addition injectable hydrogel further to capture glioblastoma/glioblastoma stem-like cells through CXCL12-mediated chemotaxis. [Advanced Healthcare Materials] |
|
|
|
| Researchers showed that post-oncolytic HSV (oHSV) virotherapy-activated AKT signaling results in an enrichment of glioblastoma stem-like cell signatures in glioma. [Molecular Therapy Oncolytics] |
|
|
|
| Investigators evaluated novel regulators of stem cell factor expression to identify novel therapeutic strategies that could target liver CSCs. [International Journal Of Oncology] |
|
|
|
| A soft agar colony formation assay using polymerase chain reaction method was applied to evaluate tumorigencitiy of cells in cellular therapy products. [Scientific Reports] |
|
|
|
| The authors established a novel approach to capture and cultivate circulating tumor cells (CTCs) using a microfilter device. Whole blood was filtered to isolate CTCs and cells captured on the microfilter were cultured in place. [Oncology Reports] |
|
|
|
|
| Scientists summarize the characteristic features and functional mechanisms of CSC-derived exosomes/mesenchymal stem cell exosomes/cancer-associated fibroblast exosomes and their mutual impact on cancer progression and therapy resistance. [Biochimie] |
|
|
|
|
| Merck announced that the US FDA has granted full approval to KEYTRUDA for the treatment of adult and pediatric patients with unresectable or metastatic MSI-H or dMMR solid tumors that have progressed following prior treatment and who have no satisfactory alternative treatment options. [Merck] |
|
|
|
|
| April 25 – 26, 2023 Boston, Massachusetts, United States |
|
|
|
|
|
| University of Southern California – Los Angeles, California, United States |
|
|
|
| University of Texas Health Science Center – San Antonio, Texas, United States |
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| University of Pennsylvania – Philadelphia, Pennsylvania, United States |
|
|
|
| Columbia University – New York, New York, United States |
|
|
|
|